ANDA 83712, held by Watson Labs. Promethazine Hydrochloride.
As of Nov 16, 2026, ANDA 83712 (Promethazine Hydrochloride), held by Watson Labs, was first approved by FDA on Sep 21, 1973, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 21, 1973 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Promethazine Hydrochloride12.5MG ยท tablet;oral | Promethazine Hydrochloride | Discontinued |
| Sep 28, 1989 | Supplement 30Labeling | Approved | None posted |
| Jul 15, 1988 | Supplement 28Labeling | Approved | None posted |
| Sep 21, 1973 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters